$IX

Matsuzaki Satoru purchased $251 of IX

Matsuzaki Satoru (See remarks) purchased 7 shares of ORIX CORP (IX) at $38.22 on 2026-05-20.

Original reporting
SEC EDGAR · Matsuzaki Satoru
Published Jun 25, 2026, 10:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 25, 2026, 10:36 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IX
Neutral
high confidence
Mentioned
$IX
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IXNeutralLow
01

Why it matters

The disclosure provides incremental information about insider activity but does not include guidance, operational changes, or material corporate actions.

02

Market read

Traders may note insider buying, but the small dollar amount limits tradable impact.

03

What to watch

Insider buys can be offset by other sales not shown here; also, without context on prior transactions, it’s hard to infer trend or conviction.

Relevance 4/10Novelty 5/10Timing: filed 2026-06-25 (after-hours/market close timing not specified)

Background

The article is a SEC Form 4 insider transaction disclosure (open-market purchase) for ORIX CORP.

Company-level read

Ticker impact

$IXNeutralHigh confidence
Context

ORIX CORP (IX) is the issuer of a Form 4 showing officer/director Matsuzaki Satoru bought 7 shares at $38.22 on 2026-05-20.

Expected impact

Minimal impact; any effect is more signaling than material.

Evidence & confidence

The filing is a primary-source Form 4, but the disclosed value is only ~$251 and there is no 10b5-1 plan, making it more of a sentiment datapoint than a catalyst.

Market effects

No sector read-across; this is a single-company insider transaction with small notional value.

None indicated.

None indicated.

Counterpoint

Because the purchase is tiny (~$251) and not tied to a 10b5-1 plan, it may reflect personal liquidity/timing rather than a strong forward view.

Key entities

  • ORIX CORP

    Company whose shares were purchased; subject of the Form 4 insider transaction.

  • Matsuzaki Satoru

    Officer/director who reported the open-market purchase.

Related articles

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.